Illumina on Tuesday said its board has approved plans to spin off Grail, the early cancer screening company it founded, spun off, and then reacquired for $8 billion over the objections of ...

Illumina's attempt to prevent the ... companies must wait for our approval before a transaction can go ahead". Under EU law, the Commission can impose fines up to 10% of aggregate turnover on ...